Aaronson AJ, Morrissey RP, Nguyen CT, Willix R, Schwarz ER. Update on the safety of testosterone therapy in cardiac disease. Expert Opin Drug Saf. 2011;10(5):697-704. View abstract
Anderson SG, Heald A, Younger N, et al. Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort. Prim Care Diabetes. 2011 Oct 5 [Epub ahead of print]. View abstract
Bajoria R, Chatterjee R. Hypogonadotrophic hypogonadism and diminished gonadal reserve accounts for dysfunctional gametogenesis in thalassaemia patients with iron overload presenting with infertility. Hemoglobin. 2011;35(5-6):636-642. View abstract
Bhattacharya RK, Khera M, Blick G, Kushner H, Nguyen D, Miner MM. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011;11(1):18. View abstract
Botto H, Neuzillet Y, Lebret T, Camparo P, Molinie V, Raynaud JP. High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone. J Urol. 2011;186(4):1400-1405. View abstract
Bouvattier C, Maione L, Bouligand J, Dodé C, Guiochon-Mantel A, Young J. Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2011 Oct 18 [Epub ahead of print]. View abstract
Buvat J, Montorsi F, Maggi M, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med. 2011;8(1):284-293. View abstract
Cattabiani C, Basaria S, Ceda GP, et al. Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men. J Endocrinol Invest. 2011 Nov 8 [Epub ahead of print]. View abstract
Corona G, Rastrelli G, Balercia G, Sforza A, Forti G, Maggi M. Testosterone and cardiovascular risk in patients with erectile dysfunction. J Endocrinol Invest. 2011 Nov 8 [Epub ahead of print]. View abstract
Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165(5):687-701. View abstract
Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96(9):2643-2651. View abstract
Dobs A, McGettigan J, Norwood P, Howell J, Waldie E, Chen Y. A novel testosterone 2% gel for the treatment of hypogonadal males. J Androl. 2011 Oct 6 [Epub ahead of print]. View abstract
Drewa T, Olszewska-Słonina D, Chlosta P. Testosterone replacement therapy in obese males [review]. Acta Pol Pharm. 2011;68(5):623-627. View abstract
Francou B, Bouligand J, Voican A, et al. Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations. PLoS One. 2011;6(10):e25614. View abstract
Giagulli VA, Triggiani V, Carbone MD, et al. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism. J Sex Med. 2011;8(12):3471-3478. View abstract
Glueck CJ, Goldenberg N, Budhani S, et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res. 2011;158(4):225-234. View abstract
Grinspon RP, Bedecarrás P, Ballerini MG, et al; LAREP Group. Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. Int J Androl. 2011;34(5 Pt 2):e487-e498. View abstract
Halabi S, Collins EG, Thorevska N, Tobin MJ, Laghi F. Relationship between depressive symptoms and hypogonadism in men with COPD. COPD. 2011;8(5):346-353. View abstract
Harris RM, Weiss J, Jameson JL. Male hypogonadism and germ cell loss caused by a mutation in Polo-like kinase 4. Endocrinology. 2011;152(10):3975-3985. View abstract
Jensen MA, Hansen AM, Abrahamsson P, Nørgaard AW. Development and evaluation of a liquid chromatography tandem mass spectrometry method for simultaneous determination of salivary melatonin, cortisol and testosterone. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(25):2527-2532. View abstract
Katz DJ, Nabulsi O, Tal R, Mulhall JP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2011 Nov 1 [Epub ahead of print]. View abstract
Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011;186(3):1005-1011. View abstract
Kocoglu H, Alan C, Soydan H, et al. Association between the androgen levels and erectile function, cognitive functions and hypogonadism symptoms in aging males. Aging Male. 2011;14(4):207-212. View abstract
Lackner JE, Rücklinger E, Schatzl G, Lunglmayr G, Kratzik CW. Are there symptom-specific testosterone thresholds in aging men? BJU Int. 2011;108(8):1310-1315. View abstract
La Vignera S, Condorelli R, Vicari E, D'Agata R, Calogero A. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy. Aging Male. 2011;14(3):183-189. View abstract
La Vignera S, Condorelli RA, Vicari E, D'Agata R, Calogero AE. New immunophenotype of blood endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and late-onset hypogonadism. J Androl. 2011;32(5):509-517. View abstract
Lee A, Rubinow K, Clark RV, et al. Pharmacokinetics of modified slow-release oral testosterone over nine days in normal men with experimental hypogonadism. J Androl. 2011 Aug 25 [Epub ahead of print]. View abstract
Lee DM, Tajar A, Pye SR, et al. Association of hypogonadism with vitamin D status: the European Male Ageing Study. Eur J Endocrinol. 2012;166(1):77-85. View abstract
Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, et al. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab. 2011 Nov 9 [Epub ahead of print]. View abstract
Liao CH, Chiang HS, Yu HJ. Serum testosterone levels significantly correlate with nocturia in men aged 40-79 years. Urology. 2011;78(3):631-635. View abstract
Magon N, Singh S, Saxena A, Sahay R. Growth hormone in male infertility. Indian J Endocrinol Metab. 2011;15(suppl 3):S248-S249. View abstract
Morgentaler A. Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer. Cancer. 2011;117(17):3885-3888. View abstract
Moskovic DJ, Freundlich RE, Yazdani P, Lipshultz LI, Khera M. Subcutaneous implantable testosterone pellets overcomes noncompliance in adolescent men with Klinefelter's syndrome: case report and review of the literature. J Androl. 2011 Sep 22 [Epub ahead of print]. View abstract
Ogbera OA, Sonny C, Olufemi F, Wale A. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus. J Coll Physicians Surg Pak. 2011;21(9):517-521. View abstract
Pecori Giraldi F, Manzoni G, Michailidis J, Scacchi M, Stramba-Badiale M, Cavagnini F. High prevalence of prolonged QT interval in obese hypogonadal males. Obesity (Silver Spring). 2011;19(10):2015-2018. View abstract
Phé V, Rouprêt M. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies. Diabetes Metab. 2011 Nov 3 [Epub ahead of print]. View abstract
Quaynor SD, Kim HG, Cappello EM, et al. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril. 2011;96(6):1424.e6-1430.e6. View abstract
Rastrelli G, Corona G, Monami M, et al. Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events. J Sex Med. 2011;8(12):3433-3445. View abstract
Salonia A, Gallina A, Abdollah F, et al. Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy. World J Urol. 2011 Sep 21 [Epub ahead of print]. View abstract
Salonia A, Gallina A, Briganti A, et al. Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy. Cancer. 2011;117(17):3953-3962. View abstract
Scanavino Mde T. Sexual dysfunctions of HIV-positive men: associated factors, pathophysiology issues, and clinical management. Adv Urol. 2011;2011:854792. View abstract
Shigehara K, Namiki M. Late-onset hypogonadism syndrome and lower urinary tract symptoms. Korean J Urol. 2011;52(10):657-663. View abstract
Sinha U, Sengupta N, Mukhopadhyay P, Roy KS. Human immunodeficiency virus endocrinopathy. Indian J Endocrinol Metab. 2011;15(4):251-260. View abstract
Taniguchi H, Kawa G, Kinoshita H, Matsuda T. Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy. Aging Male. 2011;14(3):190-194. View abstract
Teerds KJ, de Rooij DG, Keijer J. Functional relationship between obesity and male reproduction: from humans to animal models. Hum Reprod Update. 2011;17(5):667-683. View abstract
Wainwright SR, Lieblich SE, Galea LA. Hypogonadism predisposes males to the development of behavioural and neuroplastic depressive phenotypes. Psychoneuroendocrinology. 2011;36(9):1327-1341. View abstract
Wong D, Gray DP, Simmonds M, Rashiq S, Sobolev I, Morrish DW. Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction. Pain Res Manag. 2011;16(5):311-316. View abstract
Yang L, Zhang SX, Dong Q, Xiong ZB, Li X. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol. 2011 Oct 12 [Epub ahead of print]. View abstract
Yurci A, Yucesoy M, Unluhizarci K, et al. Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clin Res Hepatol Gastroenterol. 2011;35(12):845-854. View abstract
